Progressive Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-31,416
Closed -$2.54M 41
2017
Q4
$2.54M Buy
31,416
+705
+2% +$56.5K 1.7% 32
2017
Q3
$2.39M Buy
30,711
+169
+0.6% +$14K 1.8% 32
2017
Q2
$2.71M Sell
30,542
-175
-0.6% -$14.8K 2.11% 29
2017
Q1
$2.48M Buy
30,717
+35
+0.1% +$2.73K 2.06% 26
2016
Q4
$2.19M Buy
30,682
+344
+1% +$27K 2% 29
2016
Q3
$2.62M Buy
30,338
+385
+1% +$33.5K 2.44% 15
2016
Q2
$2.6M Buy
29,953
+862
+3% +$69.7K 2.52% 14
2016
Q1
$2.18M Buy
29,091
+23,532
+423% +$1.77M 2.22% 21
2015
Q4
$428K Hold
5,559
0.46% 51
2015
Q3
$372K Sell
5,559
-250
-4% -$18.4K 0.43% 57
2015
Q2
$430K Sell
5,809
-1,089
-16% -$83.2K 0.47% 55
2015
Q1
$537K Buy
+6,898
New +$523K 1.85% 30

Other funds holding MDT

Progressive Investment Management's MDT Position: Q1 2018 in Review

Progressive Investment Management sold out of Medtronic (MDT) in Q1 2018, closing a stake of 31,416 shares — an estimated $2.54M sold.

Progressive Investment Management first reported a position in MDT in Q1 2015 and held it in 12 quarters. The position peaked at $2.71M in Q2 2017. 1,381 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

  • Progressive Investment Management reported no remaining Medtronic position as of Q1 2018 after selling out during the quarter.
  • Progressive Investment Management sold 31,416 Medtronic shares in Q1 2018, an estimated $2.54M.
  • Progressive Investment Management first reported a position in Medtronic in Q1 2015 and held it in 12 quarters.
  • Progressive Investment Management's Medtronic position peaked at $2.71M in Q2 2017.
  • 1,381 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on Progressive Investment Management's 13F filing for Q1 2018, filed 2 May 2018.